Emulsion formulations of testosterone for nasal administration

Abstract The nasal route has received a great deal of attention due to the many advantages of nasal delivery over parenteral administration. The male sex hormone testosterone is ineffective when administered orally due to its gut wall and first-pass metabolism. Therefore, an alternative method for d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of microencapsulation 1998, Vol.15 (2), p.197-205
Hauptverfasser: Ko, Kuang-Ta, Needham, T. E., Zia, H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 205
container_issue 2
container_start_page 197
container_title Journal of microencapsulation
container_volume 15
creator Ko, Kuang-Ta
Needham, T. E.
Zia, H.
description Abstract The nasal route has received a great deal of attention due to the many advantages of nasal delivery over parenteral administration. The male sex hormone testosterone is ineffective when administered orally due to its gut wall and first-pass metabolism. Therefore, an alternative method for delivery would he the intranasal route, if the lack of aqueous solubility can be overcome. In this study a new approach to emulsion formulations of the drug has been proposed based on the hypothesis that increased absorption is possible upon solubilization of the drug and/or prolongation of the formulation residence time in the nose. Three differently charged testosterone submicron size emulsion formulations with various zeta potentials (+24.8,-23.0 and 0.06mV) were prepared as nasal spray formulations. A dose of approximately 3.8 mg testosterone per rabbit was administered to four rabbits and the bioavailability of the emulsion formulations was assessed and compared with an i.v. formulation via solid-phase extraction, followed by an HPLC analysis method. Statistical analysis of the normalized data indicated a bioavailability of 55, 51 and 37% for positively, negatively and neutrally charged emulsions respectively. The results of this study strongly suggest that emulsion formulations have some potential to be considered for nasal delivery. Further, both the positively and negatively charged emulsion formulations provided a better bioavailability than the neutral charged emulsion, probably indicating that the charged particle interactions between emulsion globules and the mucus layer prolong the contact of drug with nasal membrane thus enhancing drug absorption.
doi_str_mv 10.3109/02652049809006849
format Article
fullrecord <record><control><sourceid>proquest_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_2178085</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79766660</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-4842dcefbaf34a313b7141fee38b8f753ce453fb20de460fee9f99bc60f745a33</originalsourceid><addsrcrecordid>eNp9kEtLxDAUhYMoOj5-gAuhC3FXzbNNUAQRXyC40XW5TROmQ9qMSYv4702dcUAEs8mB853LvQehY4LPGcHqAtNCUMyVxArjQnK1hWaEFzwXlBfbaDb5eQLkHtqPcYExFkrSXbSrBKOCihm6vutGF1vfZ9aHJGFIOmbeZoOJg4-DCb43k5n1EMFl0HRt38YhfJOHaMeCi-Zo_R-gt_u719vH_Pnl4en25jnXnOEh55LTRhtbg2UcGGF1STixxjBZS1sKpg0XzNYUN4YXOBnKKlXrJEsugLEDdLaauwz-fUybVV0btXEOeuPHWJWqLNLDCSQrUAcfYzC2Woa2g_BZEVxNnVV_OkuZk_Xwse5Ms0msS0r-6dqHqMHZAL1u4wajpJRYTtjVCmv7qUv48ME11QCfzoefDPtvi8tf8bkBN8w1BFMt_Bj6VO8_N3wBYXWZ5w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79766660</pqid></control><display><type>article</type><title>Emulsion formulations of testosterone for nasal administration</title><source>MEDLINE</source><source>Taylor &amp; Francis</source><source>Taylor &amp; Francis Medical Library - CRKN</source><creator>Ko, Kuang-Ta ; Needham, T. E. ; Zia, H.</creator><creatorcontrib>Ko, Kuang-Ta ; Needham, T. E. ; Zia, H.</creatorcontrib><description>Abstract The nasal route has received a great deal of attention due to the many advantages of nasal delivery over parenteral administration. The male sex hormone testosterone is ineffective when administered orally due to its gut wall and first-pass metabolism. Therefore, an alternative method for delivery would he the intranasal route, if the lack of aqueous solubility can be overcome. In this study a new approach to emulsion formulations of the drug has been proposed based on the hypothesis that increased absorption is possible upon solubilization of the drug and/or prolongation of the formulation residence time in the nose. Three differently charged testosterone submicron size emulsion formulations with various zeta potentials (+24.8,-23.0 and 0.06mV) were prepared as nasal spray formulations. A dose of approximately 3.8 mg testosterone per rabbit was administered to four rabbits and the bioavailability of the emulsion formulations was assessed and compared with an i.v. formulation via solid-phase extraction, followed by an HPLC analysis method. Statistical analysis of the normalized data indicated a bioavailability of 55, 51 and 37% for positively, negatively and neutrally charged emulsions respectively. The results of this study strongly suggest that emulsion formulations have some potential to be considered for nasal delivery. Further, both the positively and negatively charged emulsion formulations provided a better bioavailability than the neutral charged emulsion, probably indicating that the charged particle interactions between emulsion globules and the mucus layer prolong the contact of drug with nasal membrane thus enhancing drug absorption.</description><identifier>ISSN: 0265-2048</identifier><identifier>EISSN: 1464-5246</identifier><identifier>DOI: 10.3109/02652049809006849</identifier><identifier>PMID: 9532525</identifier><identifier>CODEN: JOMIEF</identifier><language>eng</language><publisher>Colchester: Informa UK Ltd</publisher><subject>Absorption - physiology ; Administration, Intranasal ; Animals ; bioavailability ; Biological and medical sciences ; Biological Availability ; Chemistry, Pharmaceutical ; Drug Compounding - methods ; Drug Delivery Systems - methods ; emulsions ; Emulsions - chemistry ; General pharmacology ; Hormones. Endocrine system ; Injections, Intravenous ; Medical sciences ; Nasal delivery ; Particle Size ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Rabbits ; Solubility ; Static Electricity ; testosterone ; Testosterone - chemistry ; Testosterone - pharmacokinetics ; zeta potential nasal formulations</subject><ispartof>Journal of microencapsulation, 1998, Vol.15 (2), p.197-205</ispartof><rights>1998 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1998</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-4842dcefbaf34a313b7141fee38b8f753ce453fb20de460fee9f99bc60f745a33</citedby><cites>FETCH-LOGICAL-c430t-4842dcefbaf34a313b7141fee38b8f753ce453fb20de460fee9f99bc60f745a33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.3109/02652049809006849$$EPDF$$P50$$Ginformahealthcare$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.3109/02652049809006849$$EHTML$$P50$$Ginformahealthcare$$H</linktohtml><link.rule.ids>314,777,781,4010,27904,27905,27906,59626,59732,60415,60521,61200,61235,61381,61416</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2178085$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9532525$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ko, Kuang-Ta</creatorcontrib><creatorcontrib>Needham, T. E.</creatorcontrib><creatorcontrib>Zia, H.</creatorcontrib><title>Emulsion formulations of testosterone for nasal administration</title><title>Journal of microencapsulation</title><addtitle>J Microencapsul</addtitle><description>Abstract The nasal route has received a great deal of attention due to the many advantages of nasal delivery over parenteral administration. The male sex hormone testosterone is ineffective when administered orally due to its gut wall and first-pass metabolism. Therefore, an alternative method for delivery would he the intranasal route, if the lack of aqueous solubility can be overcome. In this study a new approach to emulsion formulations of the drug has been proposed based on the hypothesis that increased absorption is possible upon solubilization of the drug and/or prolongation of the formulation residence time in the nose. Three differently charged testosterone submicron size emulsion formulations with various zeta potentials (+24.8,-23.0 and 0.06mV) were prepared as nasal spray formulations. A dose of approximately 3.8 mg testosterone per rabbit was administered to four rabbits and the bioavailability of the emulsion formulations was assessed and compared with an i.v. formulation via solid-phase extraction, followed by an HPLC analysis method. Statistical analysis of the normalized data indicated a bioavailability of 55, 51 and 37% for positively, negatively and neutrally charged emulsions respectively. The results of this study strongly suggest that emulsion formulations have some potential to be considered for nasal delivery. Further, both the positively and negatively charged emulsion formulations provided a better bioavailability than the neutral charged emulsion, probably indicating that the charged particle interactions between emulsion globules and the mucus layer prolong the contact of drug with nasal membrane thus enhancing drug absorption.</description><subject>Absorption - physiology</subject><subject>Administration, Intranasal</subject><subject>Animals</subject><subject>bioavailability</subject><subject>Biological and medical sciences</subject><subject>Biological Availability</subject><subject>Chemistry, Pharmaceutical</subject><subject>Drug Compounding - methods</subject><subject>Drug Delivery Systems - methods</subject><subject>emulsions</subject><subject>Emulsions - chemistry</subject><subject>General pharmacology</subject><subject>Hormones. Endocrine system</subject><subject>Injections, Intravenous</subject><subject>Medical sciences</subject><subject>Nasal delivery</subject><subject>Particle Size</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Rabbits</subject><subject>Solubility</subject><subject>Static Electricity</subject><subject>testosterone</subject><subject>Testosterone - chemistry</subject><subject>Testosterone - pharmacokinetics</subject><subject>zeta potential nasal formulations</subject><issn>0265-2048</issn><issn>1464-5246</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLxDAUhYMoOj5-gAuhC3FXzbNNUAQRXyC40XW5TROmQ9qMSYv4702dcUAEs8mB853LvQehY4LPGcHqAtNCUMyVxArjQnK1hWaEFzwXlBfbaDb5eQLkHtqPcYExFkrSXbSrBKOCihm6vutGF1vfZ9aHJGFIOmbeZoOJg4-DCb43k5n1EMFl0HRt38YhfJOHaMeCi-Zo_R-gt_u719vH_Pnl4en25jnXnOEh55LTRhtbg2UcGGF1STixxjBZS1sKpg0XzNYUN4YXOBnKKlXrJEsugLEDdLaauwz-fUybVV0btXEOeuPHWJWqLNLDCSQrUAcfYzC2Woa2g_BZEVxNnVV_OkuZk_Xwse5Ms0msS0r-6dqHqMHZAL1u4wajpJRYTtjVCmv7qUv48ME11QCfzoefDPtvi8tf8bkBN8w1BFMt_Bj6VO8_N3wBYXWZ5w</recordid><startdate>1998</startdate><enddate>1998</enddate><creator>Ko, Kuang-Ta</creator><creator>Needham, T. E.</creator><creator>Zia, H.</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><general>Informa</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1998</creationdate><title>Emulsion formulations of testosterone for nasal administration</title><author>Ko, Kuang-Ta ; Needham, T. E. ; Zia, H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-4842dcefbaf34a313b7141fee38b8f753ce453fb20de460fee9f99bc60f745a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Absorption - physiology</topic><topic>Administration, Intranasal</topic><topic>Animals</topic><topic>bioavailability</topic><topic>Biological and medical sciences</topic><topic>Biological Availability</topic><topic>Chemistry, Pharmaceutical</topic><topic>Drug Compounding - methods</topic><topic>Drug Delivery Systems - methods</topic><topic>emulsions</topic><topic>Emulsions - chemistry</topic><topic>General pharmacology</topic><topic>Hormones. Endocrine system</topic><topic>Injections, Intravenous</topic><topic>Medical sciences</topic><topic>Nasal delivery</topic><topic>Particle Size</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Rabbits</topic><topic>Solubility</topic><topic>Static Electricity</topic><topic>testosterone</topic><topic>Testosterone - chemistry</topic><topic>Testosterone - pharmacokinetics</topic><topic>zeta potential nasal formulations</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ko, Kuang-Ta</creatorcontrib><creatorcontrib>Needham, T. E.</creatorcontrib><creatorcontrib>Zia, H.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of microencapsulation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ko, Kuang-Ta</au><au>Needham, T. E.</au><au>Zia, H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Emulsion formulations of testosterone for nasal administration</atitle><jtitle>Journal of microencapsulation</jtitle><addtitle>J Microencapsul</addtitle><date>1998</date><risdate>1998</risdate><volume>15</volume><issue>2</issue><spage>197</spage><epage>205</epage><pages>197-205</pages><issn>0265-2048</issn><eissn>1464-5246</eissn><coden>JOMIEF</coden><abstract>Abstract The nasal route has received a great deal of attention due to the many advantages of nasal delivery over parenteral administration. The male sex hormone testosterone is ineffective when administered orally due to its gut wall and first-pass metabolism. Therefore, an alternative method for delivery would he the intranasal route, if the lack of aqueous solubility can be overcome. In this study a new approach to emulsion formulations of the drug has been proposed based on the hypothesis that increased absorption is possible upon solubilization of the drug and/or prolongation of the formulation residence time in the nose. Three differently charged testosterone submicron size emulsion formulations with various zeta potentials (+24.8,-23.0 and 0.06mV) were prepared as nasal spray formulations. A dose of approximately 3.8 mg testosterone per rabbit was administered to four rabbits and the bioavailability of the emulsion formulations was assessed and compared with an i.v. formulation via solid-phase extraction, followed by an HPLC analysis method. Statistical analysis of the normalized data indicated a bioavailability of 55, 51 and 37% for positively, negatively and neutrally charged emulsions respectively. The results of this study strongly suggest that emulsion formulations have some potential to be considered for nasal delivery. Further, both the positively and negatively charged emulsion formulations provided a better bioavailability than the neutral charged emulsion, probably indicating that the charged particle interactions between emulsion globules and the mucus layer prolong the contact of drug with nasal membrane thus enhancing drug absorption.</abstract><cop>Colchester</cop><pub>Informa UK Ltd</pub><pmid>9532525</pmid><doi>10.3109/02652049809006849</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0265-2048
ispartof Journal of microencapsulation, 1998, Vol.15 (2), p.197-205
issn 0265-2048
1464-5246
language eng
recordid cdi_pascalfrancis_primary_2178085
source MEDLINE; Taylor & Francis; Taylor & Francis Medical Library - CRKN
subjects Absorption - physiology
Administration, Intranasal
Animals
bioavailability
Biological and medical sciences
Biological Availability
Chemistry, Pharmaceutical
Drug Compounding - methods
Drug Delivery Systems - methods
emulsions
Emulsions - chemistry
General pharmacology
Hormones. Endocrine system
Injections, Intravenous
Medical sciences
Nasal delivery
Particle Size
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Rabbits
Solubility
Static Electricity
testosterone
Testosterone - chemistry
Testosterone - pharmacokinetics
zeta potential nasal formulations
title Emulsion formulations of testosterone for nasal administration
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T14%3A13%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Emulsion%20formulations%20of%20testosterone%20for%20nasal%20administration&rft.jtitle=Journal%20of%20microencapsulation&rft.au=Ko,%20Kuang-Ta&rft.date=1998&rft.volume=15&rft.issue=2&rft.spage=197&rft.epage=205&rft.pages=197-205&rft.issn=0265-2048&rft.eissn=1464-5246&rft.coden=JOMIEF&rft_id=info:doi/10.3109/02652049809006849&rft_dat=%3Cproquest_pasca%3E79766660%3C/proquest_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79766660&rft_id=info:pmid/9532525&rfr_iscdi=true